Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889–916. https://doi.org/10.1210/jc.2015-4061.

Article  CAS  PubMed  Google Scholar 

Seccia TM, Caroccia B, Gomez-Sanchez EP, Gomez-Sanchez CE, Rossi GP. The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications. Endocr Rev. 2018;39:1029–56.

PubMed  PubMed Central  Google Scholar 

Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293–300.

Article  CAS  PubMed  Google Scholar 

Mulatero P, Sechi LA, Williams TA, Lenders JWM, Reincke M, Satoh F, et al. Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020;38:1929–36.

Article  CAS  Google Scholar 

Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro M-C, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens. 2020;38:1919–28.

Article  CAS  Google Scholar 

CONN JW, LOUIS LH. Primary aldosteronism, a new clinical entity. Ann Intern Med. 1956;44:1–15. https://www.acpjournals.org/doi/abs/10.7326/0003-4819-44-1-1.

Article  CAS  PubMed  Google Scholar 

Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371:1921–6.

Article  CAS  PubMed  Google Scholar 

Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40:892–6.

Article  CAS  PubMed  Google Scholar 

Milliez P, Girerd X, Plouin P-F, Blacher J, Safar ME, Mourad J-J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243–8.

Article  CAS  PubMed  Google Scholar 

Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. lancet Diabetes Endocrinol. 2018;6:41–50.

Article  CAS  PubMed  Google Scholar 

Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811–20.

Article  PubMed  Google Scholar 

Brown JM, Robinson-Cohen C, Luque-Fernandez MA, Allison MA, Baudrand R, Ix JH, et al. The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study. Ann Intern Med. 2017;167:630–41.

Article  PubMed  PubMed Central  Google Scholar 

Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V. Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans: A Retrospective Cohort Study. Ann Intern Med. 2021;174:289–97.

Article  PubMed  Google Scholar 

Hundemer GL, Imsirovic H, Vaidya A, Yozamp N, Goupil R, Madore F, et al. Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study. Hypertension. 2022;79:178–86.

Article  CAS  PubMed  Google Scholar 

Käyser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, van der Wel MC, et al. Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis. J Clin Endocrinol Metab. 2016;101:2826–35.

Article  PubMed  Google Scholar 

Huang W-C, Lin Y-H, Wu V-C, Chen C-H, Siddique S, Chia Y-C, et al. Who should be screened for primary aldosteronism? A comprehensive review of current evidence. J Clin Hypertens. 2022;24:1194–203.

Article  Google Scholar 

Kaplan NM. Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med. 1967;66:1079–90.

Article  CAS  PubMed  Google Scholar 

Olivieri O, Ciacciarelli A, Signorelli D, Pizzolo F, Guarini P, Pavan C, et al. Aldosterone to Renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab. 2004;89:4221–6.

Article  CAS  PubMed  Google Scholar 

Mulatero P, Monticone S, Burrello J, Veglio F, Williams TA, Funder J. Guidelines for primary aldosteronism: uptake by primary care physicians in Europe. J Hypertens. 2016;34:2253–7.

Article  CAS  PubMed  Google Scholar 

Kaplan NM. Is there an unrecognized epidemic of primary aldosteronism? Con Hypertens. 2007;50:454–8.

Article  CAS  Google Scholar 

Käyser SC, Deinum J, de Grauw WJ, Schalk BW, Bor HJ, Lenders JW, et al. Prevalence of primary aldosteronism in primary care: a cross-sectional study. Br J Gen Pr J R Coll Gen Pr. 2018;68:e114–22.

Article  Google Scholar 

Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet. 1999;353:40.

Article  CAS  PubMed  Google Scholar 

Mosso L, Carvajal C, González A, Barraza A, Avila F, Montero J, et al. Primary aldosteronism and hypertensive disease. Hypertension. 2003;42:161–5.

Article  CAS  PubMed  Google Scholar 

Williams JS, Williams GH, Raji A, Jeunemaitre X, Brown NJ, Hopkins PN, et al. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens. 2006;20:129–36.

Article  CAS  PubMed  Google Scholar 

Faconti L, McNally RJ, Farukh B, Adeyemi O, Cruickshank JK, Wilkinson IB, et al. Differences in hypertension phenotypes between Africans and Europeans: Role of environment. J Hypertens. 2020;38:1278–85.

Article  CAS  PubMed  Google Scholar 

Baguet J-P, Steichen O, Mounier-Véhier C, Gosse P. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 1: Epidemiology of PA, who should be screened for sporadic PA? Ann Endocrinol. 2016;77:187–91.

Article  Google Scholar 

Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem. 2005;51:386–94.

Article  CAS  PubMed  Google Scholar 

Nishimoto K, Nakagawa K, Li D, Kosaka T, Oya M, Mikami S, et al. Adrenocortical zonation in humans under normal and pathological conditions. J Clin Endocrinol Metab. 2010;95:2296–305.

Article  CAS  PubMed  Google Scholar 

Nishimoto K, Tomlins SA, Kuick R, Cani AK, Giordano TJ, Hovelson DH, et al. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Natl Acad Sci USA. 2015;112:E4591–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lalli E, Barhanin J, Zennaro M-C, Warth R. Local Control of Aldosterone Production and Primary Aldosteronism. Trends Endocrinol Metab. 2016;27:123–31.

Article  CAS  PubMed  Google Scholar 

Nanba K, Vaidya A, Williams GH, Zheng I, Else T, Rainey WE. Age-Related Autonomous Aldosteronism. Circulation 2017;136:347–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaffe G, Gray Z, Krishnan G, Stedman M, Zheng Y, Han J, et al. Screening Rates for Primary Aldosteronism in Resistant Hypertension: A Cohort Study. Hypertension. 2020;75:650–9.

Article  CAS  PubMed  Google Scholar 

Buffolo F, Li Q, Monticone S, Heinrich DA, Mattei A, Pieroni J, et al. Primary Aldosteronism and Obstructive Sleep Apnea: A Cross-Sectional Multi-Ethnic Study. Hypertension. 2019;74:1532–40.

Article  CAS  PubMed  Google Scholar 

Pecori A, Buffolo F, Pieroni J, Forestiero V, Sconfienza E, Veglio F, et al. Primary Aldosteronism and Obstructive Sleep Apnea: Casual Association or Pathophysiological Link? Horm Metab Res = Horm und Stoffwechselforsch = Horm Metab. 2020;52:366–72.

Article  CAS  Google Scholar 

Rossi GP, Bolognesi M, Rizzoni D, Seccia TM, Piva A, Porteri E, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension. 2008;51:1366–71.

Article  CAS  PubMed  Google Scholar 

Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C, et al. Remodeling of the left ventricle in primary aldosteronism due to Conn’s adenoma. Circulation. 1997;95:1471–8.

Article  CAS  PubMed  Google Scholar 

Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007;50:911–8.